Insider trades
Corrine Savill, Chief Officer of Cullinan Therapeutics CGEM, has filed 0 purchases and 5 sales on the open market. The latest trade was on 02/18.
Corrine Savill
Chief Business Officer
- Company
- Cullinan Therapeutics CGEM
- First filing
- 23/02/21
- Trades
- 21 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- No record
- Last trade
- 02/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/02/01 | 24/02/02 | 40,000 sh | $16.18 | $647,200 | −19.4% | |
| Open-market sale10b5-1 plan | 24/01/29 | 24/01/30 | 40,000 sh | $14.09 | $563,600 | −19.4% | |
CGEM | Open-market sale10b5-1 plan | 24/01/22–24/01/23 | 24/01/24 | 40,000 sh3 trades | $12.31avg. | $492,508.48 | −19.4% |